Tural, D. Et Al. 2020. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience. Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) , (San-Francisco, Costa Rica).

Tural, D., Olmez, O. F., Sumbul, A. T., Artac, M., Ozhan, N., Akar, E., ... Cakar, B.(2020). Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience . Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Costa Rica

Tural, DENİZ Et Al. "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience," Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Costa Rica, 2020

Tural, DENİZ Et Al. "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience." Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) , San-Francisco, Costa Rica, 2020

Tural, D. Et Al. (2020) . "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience." Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) , San-Francisco, Costa Rica.

@conferencepaper{conferencepaper, author={DENİZ TURAL Et Al. }, title={Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience}, congress name={Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)}, city={San-Francisco}, country={Costa Rica}, year={2020}}